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Topic: We performed a systematic review and meta-analysis to evaluate the beneﬁt and harms associated
with implantation of toric intraocular lenses (IOLs) during cataract surgery. Outcomes were postoperative un-
corrected distance visual acuity (UCDVA) and distance spectacle independence. Harms were evaluated as
surgical complications and residual astigmatism.
Clinical Relevance: Postoperative astigmatism is an important cause of suboptimal UCDVA and need for
distance spectacles. Toric IOLs may correct for preexisting corneal astigmatism at the time of surgery.
Methods: We performed a systematic literature search in the Embase, PubMed, and CENTRAL databases
within the Cochrane Library. We included randomized clinical trials (RCTs) if they compared toric with non-toric
IOL implantation ( relaxing incision) in patients with regular corneal astigmatism and age-related cataracts. We
assessed the risk of bias using the Cochrane Risk of Bias tool. We assessed the quality of evidence across
studies using the GRADE proﬁler software (available at: www.gradeworkinggroup.org).
Results: We included 13 RCTs with 707 eyes randomized to toric IOLs and 706 eyes randomized to non-toric
IOLs; 225 eyes had a relaxing incision. We found high-quality evidence that UCDVA was better in the toric IOL
group (logarithm of the minimum angle of resolution [logMAR] mean difference, 0.07; 95% conﬁdence interval
[CI], 0.10 to 0.04) and provided greater spectacle independence (risk ratio [RR], 0.51; 95% CI, 0.36e0.71) and
moderate quality evidence that toric IOL implantation was not associated with an increased risk of complications
(RR, 1.73; 95% CI, 0.60e5.04). Residual astigmatism was lower in the toric IOL group than in the non-toric IOL
plus relaxing incision group (mean difference, 0.37 diopter [D]; 95% CI, 0.55 to 0.19).
Conclusions: Wefound that toric IOLsprovidedbetterUCDVA,greaterspectacle independence,and loweramounts
of residual astigmatism than non-toric IOLs even when relaxing incisions were used. Ophthalmology 2016;123:275-
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Supplemental material is available at www.aaojournal.org.During cataract surgery, the refractive status of the patient is
changed. Some intraocular lenses (IOLs) correct spherical
refractive errors, whereas others correct both spherical and
astigmatic errors. Preoperative astigmatism 1.5 diopters (D) or
greater is present in 20% of patients undergoing operation for
age-related cataracts.1 Residual postoperative astigmatism is
an important cause for not obtaining planned emmetropia
after cataract surgery.2 Patients are 34 times more likely to
use spectacles per diopter of astigmatic error in the better
eye,3 and residual postoperative astigmatism is an important
reason for spectacle use even in patients with a spherical
equivalent refraction 0.5 D. Correcting residual
astigmatism results in signiﬁcantly improved visual acuity at
all contrast levels at both distance and near.4
Astigmatism can be corrected by implanting a toric IOL
or by changing the corneal curvature by LASIK or similar
procedures, or by placing relaxing incisions at the steepest
meridian to ﬂatten the corneal curvature.5 Relaxing incisions 2016 by the American Academy of Ophthalmology
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by Elsevier Inc.may correct up to 3 D of astigmatism, whereas toric IOLs
can correct up to 8 D of astigmatism.6 There are beneﬁts
and harms associated with toric IOLs and relaxing
incisions. Toric IOLs can rotate. Small rotations do not
affect the astigmatic power, but larger rotations will
reduce the power of the IOL, for example, the correcting
effect is eliminated if the IOL is rotated 30 degrees.7
Thus, larger rotations, generally 10 degrees is used as a
limit,8 require surgical interventions to reposition the IOL.
Relaxing incisions may be a site of infectious keratitis,
and the refractive result may change over time as the
cornea heals. Long-term stability studies of corneal-
relaxing incisions are scarce, but it has been reported that
the surgically induced astigmatism changes most in the ﬁrst
10 weeks after surgery, with little change from 10 weeks up
to 3 years after surgery.9 Toric IOLs show the greatest
rotation in the early postoperative period with little
rotation after 1 week.10275http://dx.doi.org/10.1016/j.ophtha.2015.10.002
ISSN 0161-6420/15
Ophthalmology Volume 123, Number 2, February 2016We conducted the present systematic review and meta-
analysis to evaluate the beneﬁts and potential harms of
toric implantation to correct preexisting corneal astigmatism
in patients undergoing phacoemulsiﬁcation for age-related
cataracts. Toric IOLs were compared with (1) non-toric
IOLs without further attempts to surgically correct astig-
matism and (2) non-toric IOLs combined with a relaxing
incision to correct astigmatism. The study was initiated by
an initiative of the Danish Health and Medicines Authorities
as part of providing evidence-based national guidelines on
the treatment of age-related cataracts.Methods
We performed this systematic review and meta-analysis based on
the principles described in the Grades of Recommendation,
Assessment, Development, and Evaluation (GRADE) approach.11
We chose to examine the effect of toric IOL implantation (I)
versus non-toric IOL implantation (C) in patients with age-
related cataracts and preoperative corneal astigmatism undergo-
ing phacoemulsiﬁcation (P) (PICO12). The effect (O) was evaluated
as (1) number (in percentage) of patients who obtained
postoperative spectacle independence at distance at all times, (2)
uncorrected distance visual acuity (UCDVA) (in logarithm of the
minimum angle of resolution [logMAR] or as a Snellen fraction
as measured by included studies), (3) residual astigmatism (in
diopters), and (4) number of operative and postoperative
complications including reoperations for rotated IOL. The non-
toric IOL could be combined with a relaxing incision. If
included studies reported outcomes at more than 1 time point, the
last reported time point was used in the analyses. The result of both
toric IOLs and relaxing incision should be stable at 3 months, and
none of the studies had a last reported time point earlier than 3
months postoperatively. We did not publish a protocol for the
present review.
We conducted a systematic literature search on August 26,
2015, in the Embase, PubMed.gov, and Cochrane Central Library
databases using the search term: (((((cataract) AND surgery) AND
toric iol)) OR (((cataract) AND surgery) AND toric intraocular
lens)) OR (((cataract) AND surgery) AND toric intraocular lens).
Two authors (L.K. and J.H.) evaluated the title and abstract of all
search hits for eligibility. If there was any doubt as to the eligibility
of a study, it was obtained and read in full by 2 authors (L.K. and
J.H.). Eligibility criteria were randomized controlled clinical trials
comparing the result after toric versus non-toric IOL implantation
in patients with preoperative regular corneal astigmatism and
cataract. References that reported only on outcome after toric IOL
implantation in patients with corneal ectasia, such as keratoconus,
or marginal pellucid degenerations were excluded. The implanta-
tion of non-toric IOLs could be combined with limbal or corneal-
relaxing incisions.
We assessed all included studies for risk of bias using the
Cochrane Risk of Bias tool.13 The Cochrane Risk of Bias tool
evaluates a study for risk of bias associated with patient selection
(randomization procedure and allocation of patients), study
performance (blinding of patients and personnel), outcome
detection (blinding of outcome assessors), data attrition (e.g.,
patients lost to follow-up or otherwise not accounted for), and
bias associated with the reporting of study ﬁndings or other types
of bias. Two reviewers independently assessed risk of bias and
extracted data from the included studies (L.K. and J.H.). Dis-
crepancies were solved by discussion and consensus. We extracted
data concerning prespeciﬁed outcomes (spectacle independence,
UCDVA 20/25, and rate of complications) from the included276studies and entered them into a meta-analysis using the Review
Manager Software.14
We evaluated the quality of the evidence for each prespeciﬁed
outcome across included studies using the GRADE system. We
evaluated each outcome for factors that could affect the reliability
of the outcome by looking at study limitations (risk of bias, e.g.,
lack of allocation concealment or lack of blinding of patients or
outcome assessors, incomplete accounting of patients, selective
outcome reporting, or other limitations),15 inconsistency (different
results between studies),16 indirectness (was the study population
and intervention comparable to the patient population and
intervention that is relevant to the readers of the present meta-
analysis, use of surrogate measures),17 imprecision (large
conﬁdence intervals [CIs] or the lack of statistical strength by
included studies to answer the posed question),18 and risk of
publication bias (small number of studies or small number of
included patients, lack of reporting of negative ﬁndings).19 We
prepared a summary of ﬁndings and evidence tables using the
GRADE proﬁler software.20
We analyzed dichotomous outcome data by calculating risk
ratios (RRs) and continuous outcome data by using mean differ-
ences. We used the Review Manager 5 Software14 for estimation of
overall treatment effects. We calculated pooled estimates of effects
by using random-effects models. When possible, we performed
subgroup analyses of outcomes. A priori, we analyzed toric versus
non-toric IOL and toric versus non-toric IOL in combination with
relaxing incisions and multifocal toric versus multifocal non-toric
IOL. According to Danish law, no institutional board review was
required for this systematic review.Results
We identiﬁed 626 references after a systematic literature review.
All references were screened for eligibility. After checking for
duplicates and eliminating references that were deemed “not rele-
vant” by title and abstract, we identiﬁed 25 potentially interesting
references that were obtained in full and read thoroughly. We
found 13 randomized clinical trials (RCTs) that ﬁtted our inclusion
criteria. These 13 RCTs compared the outcome after implantation
of toric IOLs with non-toric IOL implantation in patients under-
going phacoemulsiﬁcation for age-related cataract and with pre-
existing, regular corneal astigmatism.21e33 An overview of
included studies and interventions is provided in Table 1. Risk of
bias assessment of included studies is provided in Table S1
(available at www.aaojournal.org). Furthermore, 12
nonrandomized studies reporting the effect of toric IOL
implantation were identiﬁed.34e45 All nonrandomized studies and
studies not comparing toric with non-toric IOLs were excluded
from the analyses. A list of excluded studies with reasons for
exclusion is provided in Table S2 (available at
www.aaojournal.org). A diagram of the literature search is
shown in Table S3 (available at www.aaojournal.org).
The included studies differed with respect to length of follow-
up and types of IOLs used. Four studies compared toric IOL
with non-toric IOL,24,29e31 and 9 studies compared toric IOL with
non-toric IOL plus relaxing incisions (limbal or
corneal).21e23,25e28,32,33 All relaxing incisions were performed
manually. In one study, both the toric and non-toric IOLs were
multifocal.22 In total, 707 eyes were randomized to toric IOL
implantation and 706 eyes were randomized to non-toric IOL im-
plantation. Of those implanted with a non-toric IOL, 225 eyes
received a relaxing incision and 481 eyes received a non-toric IOL
only without surgical attempts to correct astigmatism. The included
studies differed with respect to the type of toric IOLs used and
nomograms used for planning the location, size, and depth of
Table 1. Overview of Interventions in Included Studies
Study ID Intervention Comparison Group Follow-up
Preoperative
Astigmatism Study Population
Freitas et al
201421
Toric IOL in both eyes (AcrySof
Toric TM, Alcon, Fort Worth,
TX)
Non-toric IOL (AcrySof Natural,
Alcon) þ limbal-relaxing
incisions in both eyes1
1þ3þ6
mos
0.75e2.5 D
(both eyes)
Toric: 15 patients (30 eyes); age
65.7 yrs
Non-toric: 16 patients (32 eyes);
age 71.8 yrs
Gangwani
et al 201422
Multifocal toric IOL (Mﬂex-T
multifocal toric IOL, Rayner
IOLs, East Sussex, UK) in 1
eye of a patient
Non-toric multifocal IOL (M-
ﬂex, Rayner IOLs) in the other
eye þ peripheral corneal-
relaxing incisions1
3 mos 1.0e2.5 D 29 eyes in both groups; age 74.8
yrs (4.6)
Hirnschall
et al 201423
Rayner T-Flex toric IOL
(Rayner) in 1 eye
C-Flex or Superﬂex non-toric
IOL (Rayner) þ 1 or 2 relaxing
peripheral corneal incisions in
the other eye1
1þ6 mos 1.0e2.5 D 60 eyes (30 patients); age 71.0 yrs
(8.4)
Holland et al
201024
Acrysof Toric (SA60T3-T5,
Alcon)
Non-toric IOL (Acrysof
SA60AT, Alcon)
1 yr 0.75 D with-
the-rule
astigmatism
or  1.0 D
against-the-
rule
astigmatism
Age 71 yrs
Toric: 241 eyes
Non-toric: 236 eyes
Lam et al
201532
TECNIS Toric IOL (Abbott
Medical Optics (Santa Ana,
CA)
TECNIS 1-piece IOL with
limbal-relaxing incision
1þ3 mos 3.0 D Age: non-toric: 67.7 yrs (6.9),
toric: 64.8 (10.3)
Toric: 31 eyes of 31 patients
Non-toric: 29 eyes of 29
patients
Liu et al
201433
Toric IOL (model and
manufacturer not speciﬁed)
Non-toric IOL (model and
manufacturer not speciﬁed) þ
peripheral corneal-relaxing
incisions2
1þ6 mos Group A:
0.75e1.5 D
Group B:
1.75e2.5 D
Age: non-toric: 70.5 yrs (8.0),
toric: 67.3 yrs (10.3)
Toric: 15 patients in Group A
and 12 in group B
Non-toric: 15 patients in Group
A and 12 in group B
Maedel et al
201425
Aspheric toric IOL (Lentis Unico
L-312T, Oculentis GmbH,
Berlin, Germany)
Aspheric non-toric IOL (Lentis
Unico L-312, Oculentis
GmbH) þ opposite clear
corneal incisions3
1 hr, 1 wk,
3þ9
mos
1.04e2.11 D
(mean 1.69,
SD 0.41)
Age 70.1 yrs (11.8)
Toric: 18 eyes
Non-toric: 21 eyes
Mendicute
et al 200926
Toric IOL (Acrysof Toric
SN60T3, SN60T4, SN60T5,
Alcon)
Non-toric IOL (AcrySof
SN60AT, Alcon) þ opposite
clear corneal incisions4
3 mos 1e3 D Toric: 20 eyes; age 69.3 yrs (8.2)
Non-toric: 20 eyes; age 71.9 yrs
(6.8)
Mingo-Botin
et al 201027
Toric IOL (Acrysof Toric,
Alcon)
Non-toric IOL (Acrysof Natural,
Alcon) þ peripheral corneal-
relaxing incisions5
3 mos 1e3 D Toric: 20 eyes; age 71.5 yrs (11.1)
Non-toric: 20 eyes; age 75.6 yrs
(5.9)
Titiyal et al
201428
Toric IOL (AcrySof IQ Toric,
Alcon)
Non-toric IOL (AcrySof IQ,
Alcon) þ astigmatic
keratotomy6
1 day, 1
wk, 1þ3
mos
1.25e3 D Toric: 17 eyes; age 60.7 yrs (5.99)
Non-toric: 17 eyes; age 62.23 yrs
(3.29)
Visser et al
201429
Toric IOL (AcrySof aspheric
toric, SN6AT3-T9, Alcon)
Non-toric IOL (AcrySof aspheric
non-toric, Alcon, SN60WF)
1 wk,
1þ3þ6
mos
1.25 D Age 74 yrs
Toric: 41 patients (82 eyes)
Non-toric: 45 patients (90
eyes)
Waltz et al
201530
Toric IOL (TECNIS toric
ZTC150, Abbott Medical
Optics)
Non-toric IOL (TECNIS 1-piece
ZCB00 IOL, Abbott Medical
Optics)
1 day, 1
wk,
1þ3þ6
mos
0.75e1.5 D Toric: 102 patients; age 71.3 yrs
(9.1)
Non-toric: 95 patients; age 69.9
yrs (7.6)
Zhang et al
201131
Toric IOL (AcrySof Toric
SN60T3-5, Alcon)
Non-toric (AcrySof non-toric
SN60AT, Alcon)
1þ3þ6
mos
0.5e3 D
in both eyes
Toric: 30 patients (60 eyes); age
67 yrs (10)
Non-toric: 30 patients (60 eyes);
age 65 yrs (12)
D ¼ diopter; IOL ¼ intraocular lens; SD ¼ standard deviation.
All included studies were randomized clinical trials. All included patients had age-related cataract and regular astigmatism. Values are reported in mean (SD)
or mean only if SD was not available. Age is reported in years. Nomograms used to plan size and location of incisions: (1) www.lricalculator.com according to
Donnenfeld’s nomogram; (2) surgeon’s experience plus the method of Gill and Gayton; (3) not reported; (4) surgeon’s personalized nomogram; (5)
Nichamin’s nomogram47; (6) no nomogram was used, paired 30-degree arcuate keratotomy incisions were made in the 7.0-mm optical zone on the steeper
meridian. All incisions were performed manually.
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Ophthalmology Volume 123, Number 2, February 2016relaxing incisions, but all studies compared the toric version of 1
IOL with the non-toric version of the same IOL from 1 manufac-
turer except 1 study that did not report the manufacturer or model
of IOLs used.33 The majority of studies used the AcrySof Toric
IOL from Alcon (Fort Worth, TX),21,24,26e29,31 1 study used the
Mﬂex-T multifocal IOL from Rayner (East Sussex, UK),22 1 study
used the Lentis Unico from Oculentis GmbH (Berlin, Germany),25
and 2 studies used the TECNIS toric IOL from Abbott Medical
Optics (Santa Ana, CA).30,32 Relaxing incisions were planned
using the www.lricalculator.com software,46 which is based on the
nomograms by Donnenfeld and Nichamin in 3 studies,21e23 1
study27 used Nichamin’s nomogram,47 and the remaining studies
used a personalized method26,28,33 or did not report25 how
relaxing incisions were planned. Preoperative astigmatism ranged
from 0.75 D and generally up to 3 D.
Next, we focus on beneﬁts (postoperative visual acuity and
spectacle independence) and harms (perioperative and post-
operative complications and residual astigmatism) associated with
toric and non-toric IOL implantation.
Postoperative Visual Acuity
Postoperative visual acuity was evaluated as UCDVA (logMAR in
mean [standard deviation]) reported by included studies and by the
number of patients who did not achieve an uncorrected post-
operative visual of 20/25 or better (¼ 0.10 logMAR). Mean visual
acuities were evaluated at the latest reported follow-up, which
ranged from 3 months,22,25e28 6 months,21,23,29e31,33 to 1 year.24
There were no signiﬁcant differences between visual outcomes at
3 or 6 months.
Postoperative UCDVA was signiﬁcantly better in the eyes
implanted with a toric IOL than in those implanted with a non-toric
IOL (Fig 1). The mean difference (95% CI) for all eyes was 0.07
logMAR (0.10 to 0.04) better in patients implanted with toric
IOLs. It was 0.10 logMAR (0.17 to 0.04) better when
comparing eyes with toric IOLs with non-toric IOLs. For eyes
implanted with toric IOLs, it was 0.06 logMAR (0.10
to 0.02) better than in eyes implanted with non-toric IOLs in
combination with a relaxing incision. Each letter counts 0.02 units
when visual acuity is tested using the logMAR chart at a distance
of 20 feet. Thus, 2 to 5 more letters could be read correctly without
glasses at a distance of 20 feet in eyes implanted with toric IOLs
than in eyes implanted with a non-toric IOL. There was no sig-
niﬁcant difference between subgroups (toric vs. non-toric, toric vs.
non-toric plus relaxing incision, multifocal toric vs. multifocal non-
toric, P ¼ 0.46).
Mean visual acuities may be high, although some patients end
up with a poor visual acuity. Therefore, we also evaluated post-
operative visual acuity as the prevalence of patients not obtaining
20/25 (0.10 logMAR) UCDVA. For patients randomized to toric
IOL implantation, 35.2% did not achieve 20/25 UCDVA versus
60.4% in patients randomized to non-toric IOL (both the groups
including limbal-relaxing incisions and where no further attempts
to correct astigmatism were included in this analysis). The differ-
ence between eyes randomized to toric or non-toric IOL was highly
signiﬁcant (RR, 0.59; 95% CI, 0.50e0.70; P < 0.00001), but there
was no difference among subgroups (toric vs. non-toric, toric vs.
non-toric plus relaxing incision, P ¼ 1.0) (Fig 2).
Distance Spectacle Independence
Spectacle independence was evaluated as the number of patients
who reported that they used spectacles for distance viewing
sometimes at 3 months27 or 6 months24,29e31 after surgery. The
number of patients who required spectacles for distance viewing
was signiﬁcantly lower in patients randomized to toric IOL278implantation (29.7%) than in patients randomized to non-toric IOL
implantation (53.2%) (RR, 0.51; 95% CI, 0.36e0.71) (Fig 3). In
other words, in the toric IOL groups, 70.3% never required
spectacles for distance viewing compared with 46.8% in the non-
toric IOL groups even in combination with a relaxing incision.
There was no difference between subgroups (toric vs. non-toric,
toric vs. non-toric plus relaxing incision) (P ¼ 0.67) or at 3 or 6
months follow-up.
Harms Associated with Toric Intraocular Lens
Implantation
The prevalence of postoperative complications was reported by 6
studies.21,24,26,27,29,30 A summary of all complications encountered
is shown in Table 2. A total of 23 of the 554 patients randomized to
toric IOL implantation (4.2%) experienced a postoperative
complication versus 11 of 478 patients randomized to non-toric
IOL implantation (2.3%). There was no signiﬁcant difference be-
tween the groups (RR, 1.73; 95% CI, 0.60e5.04) (Fig 4). In the
toric group, 1 eye had a retinal detachment and 5 eyes received
treatment for retinal tears postoperatively versus 1 eye with a
posterior vitreous detachment without a retinal defect in the non-
toric group. Twelve patients in the toric IOL group had to un-
dergo a second procedure (including laser treatment for retinal tears
and retinal detachment surgery and realignment of rotated IOL)
versus 1 patient in the non-toric group; this difference was statis-
tically signiﬁcant (X2 P ¼ 0.013). In the toric group, 7 patients had
macular edema versus 4 patients in the non-toric group; this dif-
ference was not statistically signiﬁcant (X2 P ¼ 0.72).
On average, the toric IOLs rotated less than 5 degrees except for
1 IOL (Lentis Unico L-312T, Oculentis GmbH) that rotated
approximately 20 degrees and was removed from the market
shortly after the study (Table 2).
Residual astigmatism at 3 months22,25e28 to 6 months23,29,30,33
after surgery was on average 0.75 D lower in the toric groups than
in the non-toric groups (mean difference, 95% CI, 1.46
to 0.05), and it was 0.37 D lower in the groups randomized to
toric IOL implantation compared with non-toric IOL plus relaxing
incision (mean difference, 95% CI, 0.55 to 0.19) (Fig 5). There
were no signiﬁcant differences between the amount of residual
astigmatism at 3 and 6 months follow-up (P ¼ 0.61).
Quality of the Evidence
Table 3 provides a summary of the evidence and a grading of
quality of evidence according to the GRADE system. Generally,
the quality of evidence was rated as high except for the
prevalence of postoperative complications that was graded as
moderate quality because a large number (5/13) of the included
RCTs did not report or comment on perioperative or
postoperative complications.
Discussion
We performed a systematic review and meta-analysis to
examine the effect of toric IOL implantation during cataract
surgery in patients with age-related cataracts and regular
corneal astigmatism. A total of 13 randomized trials were
included in the meta-analysis comprising 707 eyes random-
ized to toric IOL implantation and 706 eyes randomized to
non-toric IOL implantation.21e33 In 225 eyes, the non-toric
IOL was combined with a relaxing incision. We found
high-quality evidence that toric IOL implantation provides
better UCDVA and greater distance spectacle independence
Figure 1. Forest plot comparing uncorrected distance visual acuity (UCDVA) in eyes randomized to implantation with a toric or non-toric intraocular lens
(IOL). Visual acuity was 0.07 logarithm of the minimum angle of resolution (logMAR) better in the toric group compared with the non-toric groups. CI ¼
conﬁdence interval; IV ¼ inverse variance; SD ¼ standard deviation.
Figure 2. Forest plot showing the number of patients who did not achieve 20/25 UCDVA and the risk ratios (RRs) for not obtaining 20/25 UCDVA. A
signiﬁcantly greater number of patients did not achieve 20/25 UCDVA in the non-toric groups. CI ¼ conﬁdence interval; IOL ¼ intraocular lens; M-H ¼
ManteleHaenszel; SD ¼ standard deviation.
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Figure 3. Forest plot showing the number of patients who reported that they required spectacles for distance viewing, as well as the RRs for needing
spectacles for distance viewing. Spectacle independence was signiﬁcantly greater in the toric group. CI ¼ conﬁdence interval; IOL ¼ intraocular lens; M-
H ¼ ManteleHaenszel.
Ophthalmology Volume 123, Number 2, February 2016than implantation of non-toric IOL or non-toric IOLs com-
bined with a relaxing incision. We found moderate-quality
evidence that toric IOL implantation was not associated
with increased harms, and we found high-quality evidence
that the residual astigmatism was lower in patients who
received a toric IOL than in patients implanted with a non-
toric IOL combined with a relaxing incision.
Study Strengths and Limitations
The present study has strengths and weaknesses. It is an
inherent part of the design of systematic reviews that they
rely on published ﬁndings by other authors and on how
those authors chose to report their ﬁndings. For the present
review, we included randomized trials that compared toric
with non-toric IOL implantation  relaxing incisions. The
majority of studies were small with an included number of
approximately 20 eyes in each group. However, the strength
of a systematic review and meta-analysis is that information
from many studies is combined, and with the total number
of randomized patients in the included studies we can say
with conﬁdence that UCDVA is better, spectacle indepen-
dence is greater, and residual astigmatism is lower in pa-
tients implanted with toric IOLs than in patients implanted
with non-toric IOLs regardless of whether it is in combi-
nation with a relaxing incision or not. When it comes to the
risk of complications and harms associated with the proce-
dure, we did not ﬁnd an overall difference between the
groups, but we may not have sufﬁcient power to say there is
no difference between the groups. Thus, if more randomized
trials comparing toric with non-toric  relaxing incisions are280to be conducted, the emphasis should be on reporting harms
and complications associated with the procedure.
The level of preoperative corneal astigmatism was
approximately 0.75 to 3 D in the included RCTs. The
studies did not report ﬁndings in a way that allowed for
subgroup analysis of different degrees of preoperative
astigmatism except for 1 study that included only 27 eyes in
both the low (0.75e1.5 D) and high astigmatism (1.75e2.5 D)
groups.33 Thus, we cannot conclude from the present study
at which degree of astigmatism toric IOLs should be used or
which level of astigmatism the outcome after toric IOL
implantation exceeds that of relaxing incisions. After
cataract surgery, 60% of patients report they wear glasses
for distance viewing sometimes or always when the
postoperative astigmatism exceeds 0.75 D in the better
eye.3 Thus, it may seem advisable to inform the patient of
the potential for astigmatism correction during cataract
surgery if the surgeon expects that the postoperative
astigmatism will exceed 0.75 D.
The amount of residual astigmatism was signiﬁcantly
lower in the toric group compared with the non-toric and
non-toric in combination with relaxing incisions. The mean
amount of postoperative astigmatism was in the range of
0.18 to 0.77 D in the groups randomized to toric IOL and
0.48 to 1.32 D in the groups randomized to non-toric IOL
plus relaxing incision. The average difference between the
groups was 0.75 D for patients randomized to toric versus
non-toric IOL and 0.37 D for patients randomized to toric
versus non-toric plus relaxing incisions. Thus, although the
differences were signiﬁcant and toric IOLs are better at
compensating for astigmatism than relaxing incisions, some
Table 2. Overview of Harms in Included Studies
Study ID Rotation* Perioperative Complications Postoperative Complications Second Surgical Procedures
Freitas et al 201421 e None encountered None encountered None encountered
Gangwani et al 201422 2.52 (1.97) Not reported Not reported Not reported
Hirnschall et al 201423 2.5 (1.8) Not reported Not reported Not reported
Holland et al 201024 <4 Not reported Toric group: 6 eyes with macular
edema
Non-toric group: 2 eyes with macular
edema
Toric group: 1 eye had retinal
detachment; 1 eye had IOL
repositioning because of rotation,
followed by second surgery for IOL
replacement; 1 eye had
paracentesis for elevated
postoperative IOP; 1 eye
underwent focal laser treatment for
diabetic macular edema; 1 eye had
laser photocoagulation for
treatment of a retinal tear
Non-toric group: 1 eye had
crystalline lens fragment removal
Lam et al 201532 7.67 (4.04) None encountered None encountered None encountered
Liu et al 201433 Not reported None encountered None encountered Not reported
Maedel et al 201425 19.90 (14.48) Not reported Not reported Not reported
Mendicute et al 200926 3.53 (1.97) Not reported None encountered None encountered
Mingo-Botin et al 201027 3.65 (2.96) Not reported Toric group: none encountered
Non-toric group: 1 eye with central
de-epithelialization requiring
bandage contact lens treatment
None encountered
Titiyal et al 201428 4.8 (1.2) Not reported None encountered None encountered
Visser et al 201429 3.6 (3.2) Toric group: 1 eye with small
anterior capsule tear.
Non-toric group: 1 eye with
zonulolysis; 1 eye with large
anterior to posterior
capsule tear.
Toric group: 1 eye with high IOP;
1 eye with cystoid macular edema;
1 eye with macular pucker. Non-
toric group: 2 eyes with high IOP;
2 eyes with cystoid macular edema;
1 eye with anterior uveitis; 1 eye
with posterior vitreous detachment
without retinal defect
Toric group: 1 eye had IOL
repositioning; 1 eye with posterior
vitreous detachment with a retinal
defect
Non-toric group: none encountered
Waltz et al 201530 2.7 (5.51) Not reported Not reported Toric group: 1 eye with a rotated IOL
(that was not repositioned) had a
retinal tear and received
treatment; 4 eyes had IOL
repositioning; 2 eyes had retinal
repair procedures
Non-toric group: none reported
Zhang et al 201131 - Not reported Not reported Not reported
IOL ¼ intraocular lens; IOP ¼ intraocular pressure.
*The IOL rotation is reported in degrees as mean (SD). Complications are reported as number of eyes.
Kessel et al  Toric IOLs in Cataract Surgery: A Systematic Reviewsurgeons may ﬁnd the difference to be too small to be
clinically signiﬁcant.
The present review was focused on the effect of toric IOL
implantation in patients with regular corneal astigmatism
and age-related cataract. Toric IOLs are used for wider in-
dications; however, evidence-based evaluation of toric IOLs
for these purposes is beyond the scope of this review.
Positive results have been demonstrated in patients with
high degrees of irregular astigmatism after penetrating ker-
atoplasty,48,49 in patients with pellucid marginal degenera-
tion,50 and in astigmatic patients undergoing refractive lens
exchange.51,52
Toric IOLs are more expensive than non-toric IOLs, but
economic analyses have shown that the lifetime costs are
reduced if toric IOLs are implanted in patients withpreoperative corneal astigmatism because of the reduced
need for postsurgical spectacles.53 Relaxing incisions are
cheaper than toric IOLs, but as we have demonstrated in
the meta-analyses presented in this study, relaxing in-
cisions are inferior to toric IOLs in regard to postoperative
UCDVA and residual astigmatism, at least in the patients in
the included studies who had preoperative astigmatism in
the range of 0.75 to 3.0 D. This information should be
conveyed to patients when they decide, in collaboration with
the surgeon, which surgical approach should be used.
We chose spectacle independence for distance viewing at
all times as an important outcome. Nearly all patients will
require spectacles for reading and near vision tasks after
surgery unless multifocal IOLs are implanted or monovision
is planned. If patients require distance spectacles, sometimes281
Table 3. Quality of Evidence and Summary of Findings
Outcomes
No. of
Participants
(Studies)
Quality of the
Evidence (GRADE)
Relative Effect
(95% CI)
Anticipated Absolute Effects
Risk with
Non-Toric IOL Risk Difference with Toric IOL (95% CI)
UCDVA (logMAR)
Toric IOL vs. non-toric IOL 486 (3 studies) 4444
High
The mean UCDVA was 0.10 better (0.17e0.04 better) in the
toric group
Toric IOL vs. non-toric IOL þ relaxing
incision
385 (9 studies) 4444
High
The mean UCDVA was 0.06 better (0.10e0.02 better) in the
toric group
Multifocal toric IOL vs. multifocal non-
toric IOL þ relaxing incision
52 (1 study) 4442
Moderate*
due to imprecision
The mean UCDVA was 0.05 better (0.13 better to 0.03 worse)
in the toric group
UCDVA 20/25
Toric IOL vs. non-toric IOL 562 (2 studies) 4444
High
RR 0.57 (0.41e0.78) 603 per 1000 259 fewer per 1000 patients in the toric group did not obtain
UCDVA 20/25 (from 133 fewer to 356 fewer)
Toric IOL vs. non-toric IOL þ relaxing
incision
111 (3 studies) 4444
High
RR 0.57 (0.37e0.87) 607 per 1000 261 fewer per 1000 patients in the toric group did not obtain
UCDVA 20/25 (from 79 fewer to 383 fewer)
Spectacle independence at distance at all times
Toric IOL vs. non-toric IOL 769 (4 studies) 4444
High
RR 0.53 (0.33e0.85) 532 per 1000 250 fewer per 1000 patients in the toric group required
spectacles for distance viewing (from 80 fewer to 357 fewer)
Toric IOL vs. non-toric IOL þ relaxing
incision
98 (2 studies) 4444
High
RR 0.45 (0.26e0.78) 532 per 1000 293 fewer per 1000 patients in the toric group required
spectacles for distance viewing (from 117 fewer to 395 fewer)
Prevalence of postoperative complications
Toric IOL vs. non-toric IOL 921 (3 studies) 4442
Moderatey
due to publication
bias
RR 2.1 (0.66e6.72) 24 per 1000 26 more per 1000 patients in the toric group experienced a
postoperative complication (from 8 fewer to 136 more)
Toric IOL vs. non-toric IOL þ relaxing
incision
111 (3 studies) 4442
Moderatey
due to publication
bias
RR 0.33 (0.01e7.72) 18 per 1000 12 fewer per 1000 patients in the toric group experienced a
postoperative complication (from 18 fewer to 120 more)
Residual astigmatism
Toric IOL vs. non-toric IOL 364 (2 studies) 4444
High
The mean residual astigmatism was 0.75 D lower in the toric
group (1.46e0.05 lower)
Toric IOL vs. non-toric IOL þ relaxing 327 (8 studies) 4444
High
The mean residual astigmatism was 0.37 D lower in the toric
group (0.55e0.19 lower)
Multifocal IOL vs. non-toric multifocal
IOL þ relaxing incision
58 (1 study) 4444
High
The mean residual astigmatism was 0.27 D lower in the toric
group (0.55 lower to 0.01 higher)
CI ¼ conﬁdence interval; D ¼ diopter; IOL ¼ intraocular lens; logMAR ¼ logarithm of the minimum angle of resolution; RR ¼ risk ratio; UCDVA ¼ uncorrected distance visual acuity.
The basis for the assumed risk (e.g., the median control group risk across studies) is provided in the footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group
and the relative effect of the intervention (and its 95% CI).
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conﬁdence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our conﬁdence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our conﬁdence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
*Too few patients were included to ascertain whether there was any difference between the 2 groups.
yThirteen RCTs were included, but the prevalence of complications/risks associated with toric IOL implantation or relaxing incisions was described by only 6 of the included RCTs.
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Figure 4. Forest plot demonstrating the RR of postoperative complications in patients randomized to toric or non-toric IOL implantation. There were no
overall statistically signiﬁcant differences between the toric and non-toric groups. CI ¼ conﬁdence interval; IOL ¼ intraocular lens; M-H ¼
ManteleHaenszel.
Figure 5. Forest plot demonstrating the residual astigmatism in patients randomized to toric or non-toric IOL implantation. Residual astigmatism was on
average 0.5 diopters (D) lower in the toric group. CI ¼ conﬁdence interval; IOL ¼ intraocular lens; IV ¼ inverse variance; SD ¼ standard deviation.
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Ophthalmology Volume 123, Number 2, February 2016they will have to buy new spectacles after surgery, and the
beneﬁt of perioperative astigmatism correction is lost. We
found that 70.3% of patients reported that they never
required spectacles for distance viewing after toric IOL
implantation compared with 46.8% in both the non-toric
IOL and the non-toric plus relaxing incision groups. Thus,
in terms of the decision to purchase or not to purchase
distance glasses after cataract surgery, there is little beneﬁt
for patients who receive a relaxing incision compared with
patients who receive no surgery to correct the astigmatism.
Precise preoperative biometry and IOL calculation are
prerequisites for optimum refractive outcome after cataract
surgery. The toric IOL and relaxing incisions both counteract
the corneal component of total ocular astigmatism, whereas
the astigmatic component from the lens disappears when the
lens is removed during phacoemulsiﬁcation. Corneal astig-
matism is composed of contributions from the anterior and
posterior corneal surface. The axis orientation changes with
age from a with-the-rule dominance in younger years to
against-the-rule dominance in older age groups; the change is
most dominant for the anterior corneal curvature.54 Thus, the
ratio between anterior and posterior corneal curvature is not
constant throughout life. Although the contributions from the
posterior corneal curvature are small, they are signiﬁcant55
and the main cause for astigmatic refractive errors after
toric IOL implantation.56 This calls for individual
preoperative evaluation of the posterior corneal curvature.
Swept-source optical coherence tomography in combina-
tion with autokeratometry has been demonstrated to be su-
perior to topography and Scheimpﬂug imaging in predicting
toric IOL outcome because of the information from the
posterior corneal surface.57
The beneﬁts of toric IOL implantation are improved
uncorrected distance visual outcome, greater spectacle in-
dependence, and lower residual astigmatism, but it is also
important to examine whether toric IOL implantation is as
safe as the other options. We did not ﬁnd any differences in
terms of the total number of perioperative or postoperative
complications between the groups of patients randomized to
toric IOL or non-toric IOL  relaxing incisions. However,
patients randomized to toric IOL implantation had to un-
dergo signiﬁcantly more secondary surgical procedures
because of rotated IOLs and retinal tears. Retinal tears could
be related to toric IOL implantation if the surgeon has to
manipulate the IOL to place it at the correct axis. The need
for manipulation is expected to decrease with increasing
surgeon experience. If the eyes were manipulated more, this
may be reﬂected in increased postoperative inﬂammation,
but we did not ﬁnd any signiﬁcant differences in the number
of patients who had cystoid macular edema.
The astigmatic correcting effects of toric IOLs is reduced
if the IOL rotates. A retrospective study found that the axis
changed on average 1.36 degrees 2 weeks after YAG-laser
capsulotomy, but the changes were within measurement
error.58 Axis rotation leads to less correction of astigmatism
than expected preoperatively and may induce a hyperopic
shift.59 The astigmatic correcting effect is eliminated if the
IOL is rotated 30 degrees.7 In general, mean rotation was
<5 degrees in the studies included in the present review.
Only 1 toric IOL (Lentis Unico L-312T, Oculentis GmbH)284was found to be associated with signiﬁcant rotation, and it
was removed from the market shortly after conclusion of
that study.25 In our meta-analysis, 6 of 554 patients
(1.1%) randomized to toric IOL implantation required a
second surgical procedure to realign a rotated toric IOL.
However, evaluation of mean rotations may hide high de-
grees of rotation despite low mean values. Pooled estimates
of toric IOL rotation were reported by Visser et al,8 who
found that rotation greater than 10 degrees occurred in 3%
with the AcrySof Toric IOL, 20% with the Staar Toric
IOL (Staar Surgical Co, Monrovia, CA), 9% with the
MicroSil toric IOL (HumanOptics, Erlangen, Germany),
and 13% with the Rayner toric IOL.8 Conﬁdence intervals
were not provided, and thus we do not know if the
different types of toric IOLs are statistically signiﬁcantly
different. The way ﬁndings were reported in our included
studies did not allow for an evaluation of the prevalence
of toric IOLs that had rotated 10 degrees or more.
Conclusions
Toric IOLs are superior to non-toric IOLs even in combi-
nation with a relaxing incision in reducing the amount of
postoperative astigmatism and increasing postoperative
uncorrected visual acuity, but more patients have to un-
dergo a second procedure to realign the IOL and to treat
retinal tears or detachments. These conclusions are limited
to the range of preoperative astigmatism reported in
included studies (generally 0.75e3.0 D) and the duration of
follow-up (3e6 months). We recommend that patients with
regular corneal astigmatism receive a toric IOL if they are
to undergo cataract surgery for age-related cataracts and
they want postoperative spectacle independence for dis-
tance viewing.
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